UBS Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.65M | Buy |
1,298,173
+1,146,741
| +757% | +$4.56M | ﹤0.01% | 4151 |
|
|
2025
Q4 | $532K | Sell |
151,432
-381,560
| -72% | -$1.31M | ﹤0.01% | 6043 |
|
|
2025
Q3 | $1.74M | Sell |
532,992
-303,516
| -36% | -$956K | ﹤0.01% | 5090 |
|
|
2025
Q2 | $2.05M | Buy |
836,508
+188,678
| +29% | +$956K | ﹤0.01% | 4792 |
|
|
2025
Q1 | $4.32M | Buy |
647,830
+77,867
| +14% | +$769K | ﹤0.01% | 3934 |
|
|
2024
Q4 | $7.16M | Buy |
569,963
+231,829
| +69% | +$3.49M | ﹤0.01% | 3427 |
|
|
2024
Q3 | $6.25M | Sell |
338,134
-67,648
| -17% | -$1.39M | ﹤0.01% | 2835 |
|
|
2024
Q2 | $8.74M | Sell |
405,782
-103,172
| -20% | -$2.37M | ﹤0.01% | 2328 |
|
|
2024
Q1 | $13.7M | Buy |
508,954
+466,150
| +1,089% | +$13.2M | ﹤0.01% | 2005 |
|
|
2023
Q4 | $1.28M | Sell |
42,804
-215,425
| -83% | -$4.75M | ﹤0.01% | 4275 |
|
|
2023
Q3 | $5.29M | Buy |
258,229
+230,812
| +842% | +$4.2M | ﹤0.01% | 2513 |
|
|
2023
Q2 | $545K | Sell |
27,417
-88,737
| -76% | -$1.79M | ﹤0.01% | 4746 |
|
|
2023
Q1 | $1.99M | Sell |
116,154
-179,107
| -61% | -$3.51M | ﹤0.01% | 3434 |
|
|
2022
Q4 | $5.78M | Buy |
295,261
+198,358
| +205% | +$3.65M | ﹤0.01% | 2358 |
|
|
2022
Q3 | $1.55M | Buy |
96,903
+30,116
| +45% | +$470K | ﹤0.01% | 3385 |
|
|
2022
Q2 | $919K | Sell |
66,787
-107,410
| -62% | -$1.28M | ﹤0.01% | 3807 |
|
|
2022
Q1 | $2.76M | Buy |
174,197
+33,465
| +24% | +$578K | ﹤0.01% | 3122 |
|
|
2021
Q4 | $3.07M | Buy |
140,732
+44,829
| +47% | +$1.22M | ﹤0.01% | 3331 |
|
|
2021
Q3 | $2.87M | Buy |
95,903
+83,742
| +689% | +$3.05M | ﹤0.01% | 3246 |
|
|
2021
Q2 | $539K | Sell |
12,161
-62,052
| -84% | -$2.69M | ﹤0.01% | 4669 |
|
|
2021
Q1 | $3.29M | Buy |
74,213
+28,048
| +61% | +$1.54M | ﹤0.01% | 3032 |
|
|
2020
Q4 | $2.53M | Buy |
46,165
+25,991
| +129% | +$947K | ﹤0.01% | 3175 |
|
|
2020
Q3 | $461K | Buy |
20,174
+17,126
| +562% | +$422K | ﹤0.01% | 4259 |
|
|
2020
Q2 | $64K | Sell |
3,048
-27,360
| -90% | -$493K | ﹤0.01% | 5667 |
|
|
2020
Q1 | $425K | Sell |
30,408
-25,706
| -46% | -$509K | ﹤0.01% | 4114 |
|
|
2019
Q4 | $1.28M | Buy |
56,114
+3,763
| +7% | +$62.8K | ﹤0.01% | 3978 |
|
|
2019
Q3 | $610K | Buy |
52,351
+46,779
| +840% | +$581K | ﹤0.01% | 4386 |
|
|
2019
Q2 | $84K | Buy |
5,572
+5,562
| +55,620% | +$97.1K | ﹤0.01% | 5504 |
|
|
2019
Q1 | $0 | Sell |
10
-18,014
| -100% | -$284K | ﹤0.01% | 8080 |
|
|
2018
Q4 | $267K | Buy |
18,024
+13,009
| +259% | +$216K | ﹤0.01% | 4729 |
|
|
2018
Q3 | $123K | Buy |
5,015
+1,376
| +38% | +$29.8K | ﹤0.01% | 5410 |
|
|
2018
Q2 | $71K | Buy |
3,639
+2,061
| +131% | +$39K | ﹤0.01% | 5710 |
|
|
2018
Q1 | $29K | Buy |
+1,578
| New | +$25.7K | ﹤0.01% | 6118 |
|
|
2017
Q3 | – | Sell |
-47
| Closed | – | – | 7938 |
|
|
2017
Q2 | $0 | Sell |
47
-89
| -65% | -$664 | ﹤0.01% | 7922 |
|
|
2017
Q1 | $1K | Sell |
136
-560
| -80% | -$3.77K | ﹤0.01% | 7450 |
|
|
2016
Q4 | $17K | Buy |
696
+347
| +99% | +$9.9K | ﹤0.01% | 6615 |
|
|
2016
Q3 | $13K | Buy |
+349
| New | +$11K | ﹤0.01% | 6606 |
|
|
2016
Q2 | – | Sell |
-9,656
| Closed | -$286K | – | 7927 |
|
|
2016
Q1 | $286K | Buy |
9,656
+9,630
| +37,038% | +$289K | ﹤0.01% | 4221 |
|
|
2015
Q4 | $1K | Sell |
26
-1,336
| -98% | -$58.2K | ﹤0.01% | 8169 |
|
|
2015
Q3 | $51K | Sell |
1,362
-234
| -15% | -$10.7K | ﹤0.01% | 5812 |
|
|
2015
Q2 | $31K | Buy |
1,596
+1,359
| +573% | +$30.1K | ﹤0.01% | 6452 |
|
|
2015
Q1 | $5K | Buy |
+237
| New | +$5.56K | ﹤0.01% | 8117 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N